Masahiro Sugita
Directeur/Membre du Conseil chez HORIBA, LTD.
Profil
Masahiro Sugita is an Independent Outside Director at The 77 Bank, Ltd.
since 2013 and at Horiba Ltd.
since 2006.
He previously worked as General Director-International Department at Bank of Japan, Director-Overseas Investment Research Institute at Export-Import Bank of Japan, and Auditor at MSD (Japan) Co., Ltd.
Postes actifs de Masahiro Sugita
| Sociétés | Poste | Début |
|---|---|---|
| HORIBA, LTD. | Directeur/Membre du Conseil | 18/01/2010 |
| THE 77 BANK, LTD. | Directeur/Membre du Conseil | 01/06/2013 |
Anciens postes connus de Masahiro Sugita
| Sociétés | Poste | Fin |
|---|---|---|
| BANK OF JAPAN | Corporate Officer/Principal | - |
| Export-Import Bank of Japan | Corporate Officer/Principal | - |
MSD (Japan) Co., Ltd.
 MSD (Japan) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., MSD (Japan) Co., Ltd. is a company that focuses on Japanese domestic development pipeline. The company is based in Tokyo, Japan. The company's description states that it is a page of the clinical trial guide, which suggests that it is involved in the development and testing of new pharmaceutical products. | Comptroller/Controller/Auditor | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| HORIBA, LTD. | Producer Manufacturing |
| THE 77 BANK, LTD. | Finance |
| BANK OF JAPAN | Government |
| Entreprise privées | 2 |
|---|---|
MSD (Japan) Co., Ltd.
MSD (Japan) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., MSD (Japan) Co., Ltd. is a company that focuses on Japanese domestic development pipeline. The company is based in Tokyo, Japan. The company's description states that it is a page of the clinical trial guide, which suggests that it is involved in the development and testing of new pharmaceutical products. | Health Technology |
| Export-Import Bank of Japan | Finance |
